GE HealthCare 8-K: Officer/Director Compensation & Leadership Changes

TL;DR

**GEHC filed an 8-K about executive compensation and leadership changes, watch for details.**

AI Summary

GE HealthCare Technologies Inc. filed an 8-K on February 5, 2024, reporting an event that occurred on January 31, 2024. This filing, under Item 5.02, pertains to "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers." While the filing indicates a change in officer or director compensation, it does not provide specific names or dollar amounts in the provided text. This matters to investors because changes in executive compensation or leadership can signal shifts in company strategy, financial health, or governance, potentially impacting future stock performance.

Why It Matters

Changes in executive compensation or leadership can influence investor confidence and the company's strategic direction, directly affecting its long-term value.

Risk Assessment

Risk Level: medium — The filing indicates changes in executive compensation or leadership, which can introduce uncertainty regarding future company performance and strategy.

Analyst Insight

A smart investor would monitor subsequent filings or company announcements for specific details regarding the changes in executive compensation or leadership, as these details will provide clarity on potential impacts to company strategy and performance.

Key Players & Entities

• GE HealthCare Technologies Inc. (company) — the registrant filing the 8-K
• January 31, 2024 (date) — date of the earliest event reported
• February 5, 2024 (date) — date the 8-K was filed
• 001-41528 (other) — Commission File Number for GE HealthCare Technologies Inc.
• 500 W. Monroe Street, Chicago, IL 60661 (other) — principal executive offices address
• 833-735-1139 (other) — registrant's telephone number
• GEHC (other) — trading symbol for common stock
• The Nasdaq Stock Market LLC (other) — exchange where common stock is registered

FAQ

From the Filing

0001932393-24-000006.txt : 20240205 0001932393-24-000006.hdr.sgml : 20240205 20240205092037 ACCESSION NUMBER: 0001932393-24-000006 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240131 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240205 DATE AS OF CHANGE: 20240205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 24594265 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 gehc-20240131.htm 8-K gehc-20240131 0001932393 false 0001932393 2024-01-31 2024-01-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 31, 2024 GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)   Delaware 001-41528 88-2515116 (State or other jurisdiction of incorporation) (Commission  File Number) (IRS Employer Identification No.)       500 W. Monroe Street, Chicago, IL   60661 (Address of principal executive offices)   (Zip Code)         (Registrant’s telephone number, including area code) ( 833 ) 735-1139 ______________________________________________ (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.01 per share GEHC The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 31, 2024, Betty D. Larson, Chief People Officer, notified GE HealthCare Technologies Inc. (the “Company”) that she will be resigning from her role at the Company and that her last day at the Company will be March 21, 2024. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behal